Detalhe da pesquisa
1.
Chimeric Antigen Receptors Targeting Human Cytomegalovirus.
J Infect Dis
; 222(5): 853-862, 2020 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32285133
2.
Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
J Virol
; 92(19)2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30045984
3.
MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults.
Blood
; 129(1): 114-125, 2017 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27760761
4.
Identification of a Continuous Neutralizing Epitope within UL128 of Human Cytomegalovirus.
J Virol
; 91(6)2017 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28077639
5.
Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission.
Proc Natl Acad Sci U S A
; 112(44): 13645-50, 2015 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26483473
6.
Adoptive transfer of functional SARS-COV-2-specific immunity from donor graft to hematopoietic stem cell transplant recipients.
Am J Hematol
; 97(11): E404-E407, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36053823
7.
Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection.
J Virol
; 89(23): 11884-98, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26378171
8.
Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex.
PLoS Pathog
; 10(11): e1004524, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25412505
9.
Correction for Chiuppesi et al., "Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Responses against Human Cytomegalovirus in Mice".
J Virol
; 93(23)2019 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31723009
10.
Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus.
Commun Med (Lond)
; 4(1): 19, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38366141
11.
Highly stable and immunogenic CMV T cell vaccine candidate developed using a synthetic MVA platform.
NPJ Vaccines
; 9(1): 68, 2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38555379
12.
A lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections.
J Virol
; 86(12): 6563-74, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22491465
13.
Feline tetherin is characterized by a short N-terminal region and is counteracted by the feline immunodeficiency virus envelope glycoprotein.
J Virol
; 86(12): 6688-700, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22514338
14.
Viral vectors: a look back and ahead on gene transfer technology.
New Microbiol
; 36(1): 1-22, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23435812
15.
Synthetic multiantigen MVA vaccine COH04S1 and variant-specific derivatives protect Syrian hamsters from SARS-CoV-2 Omicron subvariants.
NPJ Vaccines
; 8(1): 41, 2023 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36928589
16.
Leflunomide Confers Rapid Recovery from COVID-19 and is Coupled with Temporal Immunologic Changes.
J Immunol Sci
; 7(1): 9-27, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36996290
17.
Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study.
Front Immunol
; 14: 1114131, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36936918
18.
Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular Therapy.
Vaccines (Basel)
; 11(9)2023 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37766168
19.
COH04S1 and beta sequence-modified vaccine protect hamsters from SARS-CoV-2 variants.
iScience
; 25(6): 104457, 2022 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35634578
20.
Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates.
NPJ Vaccines
; 7(1): 7, 2022 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35064109